(Q45152841)

10 December 2017

The dopamine D1 antagonist reduces ethanol reward for C57BL/6 mice (English)

1 reference

10 December 2017

Kimber L Price

1

1 reference

PubMed ID

15547453

10 December 2017

Lawrence D Middaugh

series ordinal

2

1 reference

10 December 2017

1 November 2004

1 reference

Alcoholism: Clinical and Experimental Research

10 December 2017

1 reference

10 December 2017

28

1 reference

10 December 2017

11

1 reference

10 December 2017

1666-1675

1 reference

What is the role of dopamine in reward: hedonic impact, reward learning, or incentive salience?

10 December 2017

1 reference

https://api.crossref.org/works/10.1097%2F01.ALC.0000145783.39748.E6

Dose-dependent effect of ethanol on extracellular dopamine in mesolimbic striatum of awake rhesus monkeys: comparison with cocaine across individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.ALC.0000145783.39748.E6

Augmentation of drug reward by chronic food restriction: behavioral evidence and underlying mechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.ALC.0000145783.39748.E6

Evidence of increased dopamine receptor signaling in food-restricted rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.ALC.0000145783.39748.E6

Determinants of increased drug self-administration due to food deprivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.ALC.0000145783.39748.E6

A clinical laboratory paradigm for evaluating medication effects on alcohol consumption: naltrexone and nalmefene

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.ALC.0000145783.39748.E6

Disruption of dopamine D1 receptor gene expression attenuates alcohol-seeking behavior.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.ALC.0000145783.39748.E6

Effects of the atypical antipsychotic remoxipride on alcohol self-administration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.ALC.0000145783.39748.E6

Effects of ecopipam, a selective dopamine D1 antagonist, on smoked cocaine self-administration by humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.ALC.0000145783.39748.E6

Dopamine receptors in the medial prefrontal cortex influence ethanol and sucrose-reinforced responding.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.ALC.0000145783.39748.E6

Ventral tegmental microinjections of quinpirole decrease ethanol and sucrose-reinforced responding.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.ALC.0000145783.39748.E6

Microinjections of dopamine agonists in the nucleus accumbens increase ethanol-reinforced responding

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.ALC.0000145783.39748.E6

Neural systems for behavioral activation and reward

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.ALC.0000145783.39748.E6

Body mass index and alcohol use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.ALC.0000145783.39748.E6

Role of muscles accumbens dopamine D1 and D2 receptors in instrumental and Pavlovian paradigms of conditioned reward.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.ALC.0000145783.39748.E6

Ethanol intake as a function of concentration during food deprivation and satiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.ALC.0000145783.39748.E6

Chronic ethanol consumption by C57BL/6 mice promotes tolerance to its interoceptive cues and increases extracellular dopamine, an effect blocked by naltrexone

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.ALC.0000145783.39748.E6

Naltrexone effects on ethanol consumption and response to ethanol conditioned cues in C57BL/6 mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.ALC.0000145783.39748.E6

Operant ethanol reward in C57BL/6 mice: influence of gender and procedural variables.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.ALC.0000145783.39748.E6

Delta-opioid and 5-HT3 receptor antagonist effects on ethanol reward and discrimination in C57BL/6 mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.ALC.0000145783.39748.E6

Effect of haloperidol on measures of craving and impaired control in alcoholic subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.ALC.0000145783.39748.E6

Repeated administration of the D1/5 antagonist ecopipam fails to attenuate the subjective effects of cocaine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.ALC.0000145783.39748.E6

Neurotransmitter and neuromodulatory mechanisms involved in alcohol abuse and alcoholism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.ALC.0000145783.39748.E6

D1 or D2 antagonism in nucleus accumbens core or dorsomedial shell suppresses lever pressing for food but leads to compensatory increases in chow consumption

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.ALC.0000145783.39748.E6

Suppression of alcohol preference in rats induced by risperidone, a serotonin 5-HT2 and dopamine D2 receptor antagonist.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.ALC.0000145783.39748.E6

Eating disorders in women who abuse alcohol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.ALC.0000145783.39748.E6

Alcohol preference and sensitivity are markedly reduced in mice lacking dopamine D2 receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.ALC.0000145783.39748.E6

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.ALC.0000145783.39748.E6

Neurobehavioural mechanisms of reward and motivation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.ALC.0000145783.39748.E6

Attenuation of the euphoric effects of cocaine by the dopamine D1/D5 antagonist ecopipam (SCH 39166)

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.ALC.0000145783.39748.E6

The dopamine hypothesis of reward: past and current status

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.ALC.0000145783.39748.E6

Pharmacological and environmental determinants of relapse to cocaine-seeking behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.ALC.0000145783.39748.E6

Differential modulation of behavioral effects of cocaine by low- and high-efficacy D1 agonists.

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.ALC.0000145783.39748.E6

Drug therapy for alcohol dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.ALC.0000145783.39748.E6

Characterization of the binding of SCH 39166 to the five cloned dopamine receptor subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.ALC.0000145783.39748.E6

Flupenthixol decanoate and relapse prevention in alcoholics: results from a placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.ALC.0000145783.39748.E6

Neurobiology of addiction

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.ALC.0000145783.39748.E6

The relationship between eating disorders and substance use: moving beyond co-prevalence research

21 January 2018

1 reference

https://api.crossref.org/works/10.1097%2F01.ALC.0000145783.39748.E6

10.1097/01.ALC.0000145783.39748.E6

21 January 2018

Identifiers

DOI

1 reference

10 December 2017

1 reference

PubMed ID

15547453